INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 160 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,155,594 | +0.3% | 116,267 | -40.2% | 0.00% | 0.0% |
| Q2 2023 | $2,149,535 | -3.8% | 194,352 | +16.8% | 0.00% | 0.0% |
| Q1 2023 | $2,234,431 | +6.3% | 166,376 | -2.1% | 0.00% | 0.0% |
| Q4 2022 | $2,101,377 | -14.8% | 169,877 | -3.8% | 0.00% | -20.0% |
| Q3 2022 | $2,465,000 | +16.6% | 176,679 | +15.4% | 0.01% | 0.0% |
| Q2 2022 | $2,114,000 | -13.8% | 153,068 | +1.6% | 0.01% | 0.0% |
| Q1 2022 | $2,452,000 | -7.5% | 150,713 | -7.4% | 0.01% | 0.0% |
| Q4 2021 | $2,652,000 | +18.0% | 162,785 | +7.6% | 0.01% | 0.0% |
| Q3 2021 | $2,247,000 | +40.3% | 151,311 | +88.6% | 0.01% | +66.7% |
| Q2 2021 | $1,602,000 | -3.4% | 80,214 | +11.7% | 0.00% | -25.0% |
| Q1 2021 | $1,658,000 | +49.4% | 71,816 | +59.9% | 0.00% | +33.3% |
| Q4 2020 | $1,110,000 | -49.5% | 44,923 | -15.2% | 0.00% | -50.0% |
| Q3 2020 | $2,197,000 | -35.8% | 52,997 | -25.8% | 0.01% | -45.5% |
| Q2 2020 | $3,423,000 | -0.1% | 71,445 | +31.3% | 0.01% | -26.7% |
| Q1 2020 | $3,426,000 | +733.6% | 54,415 | +1542.0% | 0.02% | +1400.0% |
| Q4 2019 | $411,000 | -5.5% | 3,314 | -49.5% | 0.00% | -50.0% |
| Q3 2019 | $435,000 | +83.5% | 6,557 | +119.9% | 0.00% | +100.0% |
| Q2 2019 | $237,000 | -35.4% | 2,982 | -9.2% | 0.00% | -50.0% |
| Q1 2019 | $367,000 | -47.3% | 3,283 | -40.5% | 0.00% | -33.3% |
| Q3 2018 | $697,000 | – | 5,517 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 234,375 | $23,623,000 | 22.67% |
| Boxer Capital, LLC | 600,000 | $60,474,000 | 7.47% |
| DLD Asset Management, LP | 834,600 | $84,136,000 | 5.77% |
| GREAT POINT PARTNERS LLC | 200,000 | $20,158,000 | 2.55% |
| BB BIOTECH AG | 575,719 | $58,027,000 | 1.86% |
| Elk Creek Partners, LLC | 207,657 | $20,930,000 | 1.74% |
| ALTRINSIC GLOBAL ADVISORS LLC | 277,944 | $28,014,000 | 1.34% |
| Sarissa Capital Management LP | 54,000 | $5,442,000 | 1.21% |
| QCM Cayman, Ltd. | 2,181 | $220,000 | 0.90% |
| Opus Point Partners Management, LLC | 3,534 | $356,000 | 0.78% |